Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Genprex Inc
(NQ:
GNPX
)
2.220
+0.200 (+9.90%)
Streaming Delayed Price
Updated: 12:20 PM EDT, Oct 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Genprex Inc
< Previous
1
2
3
4
5
6
7
Next >
Genprex's Lead Cancer Program Scores Second FDA Fast Track Tag For Lung Cancer Setting
January 03, 2022
The FDA has granted Fast Track Designation for Genprex Inc's (NASDAQ: GNPX) lead drug candidate, Reqorsa Immunogene combination therapy. The designation...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 03, 2022
Gainers Immix Biopharma (NASDAQ:IMMX) shares increased by 61.5% to $5.75 during Monday's pre-market session. The company's market cap stands at $43.5 million....
Via
Benzinga
Genprex Receives U.S. FDA Fast Track Designation for REQORSA™ Immunogene Therapy in Combination With Keytruda® for the Treatment of Non-Small Cell Lung Cancer
January 03, 2022
From
Genprex, Inc.
Via
Business Wire
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
August 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc...
Via
Benzinga
InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) CEO to Present in CEO Roadshow Webinar
November 16, 2021
Via
Investor Brand Network
Genprex to Present in November CEO Roadshow Webinar
November 16, 2021
From
Genprex, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 27, 2021
Gainers Nurix Therapeutics (NASDAQ:NRIX) stock moved upwards by 15.4% to $33.42 during Wednesday's regular session. Trading volume for Nurix Therapeutics's stock...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 20, 2021
Gainers Tenet Healthcare (NYSE:THC) stock r...
Via
Benzinga
InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Strengthens Management Team with Strategic Appointments
September 28, 2021
Via
Investor Brand Network
Genprex Strengthens Management Team with Appointments of Industry Leaders Mark S. Berger, M.D. as Chief Medical Officer and Hemant Kumar, Ph.D. as Chief Manufacturing and Technology Officer
September 28, 2021
From
Genprex, Inc.
Via
Business Wire
InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Participation in Two Upcoming Investor Conferences
September 20, 2021
Via
Investor Brand Network
Genprex to Participate in September Investor Conferences
September 20, 2021
From
Genprex, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
August 26, 2021
Gainers MorphoSys (NASDAQ:MOR) stock move...
Via
Benzinga
Genprex to Participate in a Monthly CEO Roadshow Webinar Series
July 20, 2021
From
Genprex, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 23, 2021
Gainers Orphazyme (NASDAQ:ORPH) shares moved upwards by 32.66% to $7.92 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of...
Via
Benzinga
Genprex Announces Initiation of its Phase 1/2 Acclaim-1 Clinical Trial for REQORSA™ Immunogene Therapy in Combination with Tagrisso® to Treat Non-Small Cell Lung Cancer Following FDA Review
June 23, 2021
From
Genprex, Inc.
Via
Business Wire
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
July 16, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) IVERIC bio, Inc. (NASDAQ:...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 18, 2021
Gainers AnPac Bio-Medical Science (NASDAQ:ANPC) stock rose 21.47% to $5.26 during Friday's pre-market session. The company's market cap stands at $68.5 million....
Via
Benzinga
Genprex Announces Participation in Noble Capital Markets’ Virtual Roadshow Series
May 19, 2021
From
Genprex, Inc.
Via
Business Wire
Genprex to Participate in Upcoming May Investor Conferences
May 10, 2021
From
Genprex, Inc.
Via
Business Wire
Genprex In-Licenses Additional Gene Therapy Technologies for Treatment of Lung Cancer
May 06, 2021
From
Genprex, Inc.
Via
Business Wire
Diamond Equity Research Emerging Growth Invitational Spring 2021 Virtual Conference
May 06, 2021
- One Day Conference May 11, 2021 - 25 Minute Presenting Time Slots From 8:30am to 1:25pm EST - Presentation Times and Links Distributed for All Presenting Companies - Investors Will Be Provided Time...
From
Diamond Equity Research LLC
Via
AccessWire
Genprex Announces Centralized Institutional Review Board Approval for Acclaim-1 Clinical Trial in Non-Small Cell Lung Cancer
May 05, 2021
From
Genprex, Inc.
Via
Business Wire
Genprex Initiates Site Recruitment for Acclaim-2 Clinical Trial for the Treatment of Non-Small Cell Lung Cancer
May 04, 2021
From
Genprex, Inc.
Via
Business Wire
Genprex to Participate in CEO Roadshow Webinar Series
April 21, 2021
From
Genprex, Inc.
Via
Business Wire
Genprex to Receive Inaugural “License of the Year” Award from University of Pittsburgh Innovation Institute in Recognition of Advances Made with Gene Therapy Program in Diabetes
April 20, 2021
From
Genprex, Inc.
Via
Business Wire
Genprex Collaborators Report Positive Preclinical Data for REQORSA™ Immunogene Therapy in Non-Small Cell Lung Cancer at the 2021 AACR Annual Meeting
April 12, 2021
From
Genprex, Inc.
Via
Business Wire
44 Biggest Movers From Yesterday
April 09, 2021
Gainers Chemomab Therapeutics Ltd. (NASDAQ: CMMB) shares jumped 111.5% to close at $55.00 on Thursday. ORBCOMM Inc. (NASDAQ: ORBC) gained 52.1% to close at $11.51 on Thursday. GI...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.